Tag: bisantrene cGMP API manufacturing
Aussie biotech firm completes bisantrene cGMP API manufacturing with Indian partner
Race Oncology Limited announced that Laurus Labs, an India-based pharmaceutical manufacturer, has produced its first batch of bisantrene dihydrochloride, Race’s active pharmaceutical ingredient (API), to a standard that meets the quality specified under the ‘Code of Good Manufacturing Practice’ (cGMP).
Featured Article
APS Industrial expands regional footprint with Control Technologies acquisition
APS Industrial (APS) is expanding its regional presence through the acquisition of Albury-based Control Technologies, a move the industrial products supplier said will strengthen its local service capability and support further investment in warehousing, stockholding and technical support.
